Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) is taking significant strides in expanding its philanthropic reach to support underprivileged cancer patients. At a conference held at its Rohini Centre in Delhi, RGCIRC unveiled a comprehensive plan to foster partnerships aimed at making quality cancer care more accessible and affordable.

Rakesh Chopra, Chairman of RGCIRC said, "With an initial contribution of just Rs 49 lakh, the hospital has achieved significant milestones since its incorporation. We have a corpus of Rs 100 crore and our goal is to expand this corpus to Rs 300 crore within the next three years. The interest accrued will be utilised to support economically disadvantaged patients."

Speaking at the conference, DS Negi, CEO of RGCIRC, emphasized the unique ethos of the hospital, stating, “We have spent around Rs 44 crore from our funds for the treatment of underprivileged individuals. Every contribution and support we receive is channelled towards aiding the underprivileged, and it remains our key motto.”

Dr Sudhir Rawal, MD, of RGCIRC, discussed the groundbreaking advancements in cancer treatment at RGCIRC. “RGCIRC is the first in the country to introduce cutting-edge technologies like the High-Intensity Focused Ultrasound (HIFU), robotic surgery, cyber knife and others. We are actively working towards the development of indigenous Car T cell therapy soon, and through these advancements, we continue to provide world-class oncology care.” said Dr Rawal.

Under the banner of enhancing care and facilitating early detection and treatment, the conference brought together a consortium of medical experts, industry leaders, and corporate stakeholders. This gathering underscored the critical importance of Corporate Social Responsibility (CSR) in advancing cancer care, particularly for those in dire financial need.